Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
NCT02911935Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in wheeze comparing Oral azithromycin with Placebo (2 arms). Primary endpoint: Number of Participants Who Experienced the Occurrence of a Third Episode of Post-RSV Wheezing. Started Nov 2016; status: completed.
02
Drugs
azithromycin
03
Conditions
wheeze
Beyond the preview
Go deeper on NCT02911935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02911935.